Differential Cost-Sharing Undermines Treatment Adherence to Combination Therapy: Evidence from Diabetes Treatment
Crossref DOI link: https://doi.org/10.1007/s13300-021-01098-8
Published Online: 2021-07-01
Published Print: 2021-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nelson, David R.
Heaton, Pamela
Hincapie, Ana
Ghodke, Shirin
Chen, Jieling
Funding for this research was provided by:
Eli Lilly and Company
Text and Data Mining valid from 2021-07-01
Version of Record valid from 2021-07-01
Article History
Received: 3 May 2021
Accepted: 10 June 2021
First Online: 1 July 2021